MedTrace Logo

Tdap Vaccination for Infant Caregivers

NCT01233401 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 102

Last updated 2011-07-28

No results posted yet for this study

Summary

This study evaluates whether offering Tetanus, diphteria and acellular pertussis (Tdap) vaccine to caregivers of newborn infants during pediatric well child visits increase the caregivers' vaccination rates.

Conditions

  • Pertussis
  • Vaccination

Interventions

OTHER

Survey

Mothers and Other infant caregivers are surveyed at the end of the 2 week newborn well child visit about whether they chose to receive the Tdap vaccine at the pediatrician's office.

Sponsors & Collaborators

  • Saint Raphael Healthcare System

    collaborator OTHER

  • Yale University

    lead OTHER

Principal Investigators

  • Deepa R Camenga, MD · Yale University

  • Marjorie Rosenthal, MD MPH · Yale University

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2010-12-31
Completion
2011-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01233401 on ClinicalTrials.gov